Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Updated Version of Novavax's COVID-19 Vaccine Now Approved in the EU
Friday, November 03, 2023Novavax Inc a global company advancing proteinbased vaccines with its MatrixM adjuvant today announced that the Commission European Union has approved the dispersion of Nuvaxovid
Endo Launches Colchicine Capsules, Generic Version of MITIGARE®
Friday, November 03, 2023Endo International plc announced today that one of its operating companies Par Pharmaceutical Inc has begun shipping colchicine mg capsules a generic version of Hikmas MITIGARE
Molecular Templates Announces First Patient Dosed in Phase 1 Trial Evaluating MT-8421, a Novel Engineered Toxin Body Targeting CTLA-4, in Advanced Solid Tumors
Friday, November 03, 2023Molecular Templates Inc Nasdaq MTEM Molecular Templates or MTEM a clinicalstage biopharmaceutical company developing novel therapeutics for oncology with potent differentiated mechanisms of action
Phathom Pharmaceuticals Announces FDA Approval of VOQUEZNA® (vonoprazan) Tablets for the Treatment of Erosive GERD and Relief of Heartburn Associated with Erosive GERD in Adults
Thursday, November 02, 2023Phathom Pharmaceuticals Inc a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases announced today the US Food and Drug Administration has approved VOQUEZNA
Evaxion Reveals Encouraging First Results From the Phase II Clinical Trial of Its Personalized Cancer Vaccine EVX-01
Thursday, November 02, 2023Evaxion or the Company a clinical researchfocused biotechnology company specializing in the development of vaccines based on its AI immunology platform AIImmunology is proud to announce the first results of the phase II clinical trial
Cocrystal Pharma Receives UK MHRA Authorization to Initiate Its Phase 2a Influenza Human Challenge Trial with Oral PB2 Inhibitor CC-42344
Wednesday, November 01, 2023Cocrystal Pharma Inc announces receipt of authorization from the United Kingdom Medicines and Healthcare Products Regulatory Agency to initiate a Phase a human challenge trial
Evaxion Announces Encouraging Initial Phase 2 Clinical Data on Its Personalized Cancer Vaccine EVX-01
Wednesday, November 01, 2023Evaxion Biotech AS a clinicalstage TechBio company specializing in the development of AIImmunology powered vaccines is pleased to announce initial results from the EVX Phase clinical trial
SELLAS Life Sciences Receives Fast Track Designation from FDA for SLS009 for Treatment of Relapsed/Refractory Peripheral T-cell Lymphomas
Tuesday, October 31, 2023SELLAS Life Sciences Group Inc a latestage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications today announced that the US Food and Drug Administration
Karyopharm and Bristol Myers Collaborate on Multiple Myeloma Trial with Mezigdomide and Selinexor
Tuesday, October 31, 2023Karyopharm Therapeutics Inc a commercialstage pharmaceutical company pioneering novel cancer therapies today announced that it has entered into a clinical trial collaboration and supply agreement with BristolMyers Squibb
Novartis Phase III Study Shows Significant Proteinuria Reduction in IgA Nephropathy
Monday, October 30, 2023Novartis today announced positive topline results from the interim analysis of the ongoing pivotal Phase III ALIGN study of atrasentan an oral endothelin A receptor antagonist in patients with IgA nephropathy
